Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal
Author


Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is developing an oral treatment for leukemia.

You May Also Like
Oil prices end at a 1-week high after U.S. leads strikes against Yemen over Red Sea attacks

Oil prices end at a 1-week high after U.S. leads strikes against Yemen over Red Sea attacks

Oil prices settled Friday at their highest in a week after the…
House passes bill that could lead to U.S. TikTok ban, and Senate’s OK looks likely

House passes bill that could lead to U.S. TikTok ban, and Senate’s OK looks likely

The U.S. House of Representatives has voted in favor of a revised…
‘We track our finances religiously’: Are we obliged to pay for our daughter’s medical school? We have $2.6 million saved for retirement.

‘We track our finances religiously’: Are we obliged to pay for our daughter’s medical school? We have $2.6 million saved for retirement.

“I am retired, and my wife is an employed physician. She is…
Trump’s tariffs, whether implemented or not, have already hurt the U.S. auto industry

Trump’s tariffs, whether implemented or not, have already hurt the U.S. auto industry

Claudia Assis Claudia Assis is a San Francisco-based reporter for MarketWatch. Follow…